Logatiman, Mark John .

HRN: 27-85-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
CEFUROXIME 750MG (VIAL)
09/26/2025
10/03/2025
IV
375mg
Q8
PCAP C
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines